Full-Time

Director – Commercial and Medical Systems Portfolio and Operations

Confirmed live in the last 24 hours

Revolution Medicines

Revolution Medicines

201-500 employees

Develops targeted therapies for RAS-driven cancers

Biotechnology
Healthcare

Compensation Overview

$210k - $253kAnnually

Senior, Expert

San Carlos, CA, USA

Hybrid position requiring in-office presence.

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Required Skills
Agile
Requirements
  • Entrepreneurial, enjoys working in a fast-paced, high growth, small-company environment.
  • Mastery of portfolio and project management principles and best practices with demonstrated application in large and small initiatives via multiple methodologies (waterfall, agile).
  • Superb organization, attention to detail, and accuracy. Drive to meet and exceed high expectations of quality delivery.
  • Strong leadership skills with direct and indirect people management experience in building and managing cross-functional teams.
  • 10+ years vendor management experience including contracting, daily operations/task management, budget management, performance management.
  • Demonstrated experience leading multiple concurrent projects.
  • Experience leading large/complex engagements spanning multiple years with multimillion-dollar budgets.
  • Experience with data management projects.
  • Strong understanding of Commercial and Medical business context, capabilities, systems, and data.
  • Builds rapport and credibility as a strategic partner.
  • Acts with urgency and passion. Enjoys supporting others.
  • Ability to manage a portfolio of projects, activities, and tasks simultaneously and autonomously.
  • Experience with application administration, production support, and quality assurance, including hands-on experience.
  • Passionate about continuous improvement and knowledge sharing.
  • Able to work with agility, comfortable with change, and willingness to be flexible.
  • Excellent communication skills, possessing the ability to prepare and present data and complex information in a visually appealing and easy to understand manner.
  • Adept at summarizing and communicating the appropriate information to the right audience.
  • Experience in pharma, life sciences, or a related industry.
  • Bachelor’s degree or equivalent and a minimum of 12 years in the delivery of technology services and support, including Commercial experience.
Responsibilities
  • Develop standards and best practices related to project management in the delivery of systems.
  • Partner with numerous vendors on multiple concurrent projects to roll-up status, flag dependencies and risks, and facilitate cross functional collaboration and communication.
  • Obtain and maintain a deep understanding of Commercial and Medical business needs and use cases to play a consultative role in prioritization and planning.
  • Create a shared vision of business systems launch plans and the Commercial and Medical project portfolio among stakeholders across functions and facilitate decision making related to prioritization and trade-offs.
  • Ensure delivery of projects within determined schedule, scope, and budget constraints.
  • Own daily operations of the Commercial and Medical Systems team (including but not limited to strategic planning, vendor contract management, stakeholder communication, financial management, internal KPIs and performance management, etc.).
  • Facilitate the selection, implementation, and maintenance of Commercial and Medical data platforms and tools.
  • In partnership with team leaders and business stakeholders, help develop 2-5 year technology roadmaps.
  • Lead the selection and management of project managers, quality assurance team members, and production support/administrators for Commercial and Medical Systems.
  • Demonstrate what good looks like in terms of flawless organization, attention to detail, and project execution across the organization.

Revolution Medicines develops treatments specifically for cancers caused by RAS gene mutations, which are common in difficult-to-treat cancers like pancreatic, colorectal, and lung cancers. Their main product line includes RASON Inhibitors, designed to target and inhibit RAS proteins that contribute to cancer growth. The company uses a Tri Complex Inhibitor platform to create these specialized therapies. Unlike many competitors, Revolution Medicines focuses solely on RAS-driven cancers, allowing them to carve out a niche in the oncology market. Their goal is to transform cancer treatment by providing effective targeted therapies for patients suffering from these challenging conditions.

Company Stage

IPO

Total Funding

$219.8M

Headquarters

Redwood City, California

Founded

2014

Growth & Insights
Headcount

6 month growth

15%

1 year growth

42%

2 year growth

137%
Simplify Jobs

Simplify's Take

What believers are saying

  • The acquisition of EQRx is expected to add over $1 billion in net cash, significantly bolstering Revolution Medicines' financial position.
  • Successful public offerings and underwriters' full exercise of options have brought substantial capital, indicating strong investor confidence.
  • The company's innovative RASON Inhibitors and Tri Complex Inhibitor platform have the potential to revolutionize treatment for RAS-driven cancers, offering significant clinical impact.

What critics are saying

  • The highly specialized focus on RAS-driven cancers may limit market size and revenue potential compared to broader oncology companies.
  • Integration challenges from the acquisition of EQRx could divert focus and resources, potentially impacting ongoing projects.

What makes Revolution Medicines unique

  • Revolution Medicines focuses exclusively on RAS-driven cancers, a niche but critical area in oncology, unlike broader-spectrum oncology companies.
  • Their Tri Complex Inhibitor platform allows for highly specialized treatments, setting them apart from competitors with more generalized approaches.
  • The company's revenue model, which includes licensing, co-development partnerships, and direct sales, provides multiple revenue streams, enhancing financial stability.

Help us improve and share your feedback! Did you find this helpful?